company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,552000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,552000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,552000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,440000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2389000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2829000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5658000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5106000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5119000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5119000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5119000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,540000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5659000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,3700000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.52
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,3700000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.52
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1863350.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 16:05:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.52
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,554000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,554000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,554000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,592000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3235000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3827000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3273000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3281000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3281000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3281000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,564000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3845000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.81
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.81
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2119518.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q2,2014-04-01,2014-06-30,2015-08-13 16:32:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.81
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,660000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,660000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,660000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1300000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2257000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3557000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2897000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1197000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1199000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4096000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4096000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4096000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,netincometocommon,preferreddividends,Preferred Stock Dividends Declared,-,debit,usd,328000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4424000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.08
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.08
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2124247.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:11:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.08
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2003000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4190000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,40383000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46576000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-46562000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1753000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-23174000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-24907000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-71469000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-71469000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-71469000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-71469000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2500000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-28.63
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2500000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-28.63
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2508960.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-28.63
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,107000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,107000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,107000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2197000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5718000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7915000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7808000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,50000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,50000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7758000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7758000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7758000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7758000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,25900000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,25900000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26259392.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:13:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,84000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,84000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,84000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2777000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8012000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10789000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10705000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,171000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,171000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10534000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10534000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10534000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10534000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26300000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26300000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26268610.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q2,2015-04-01,2015-06-30,2016-08-08 17:02:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,57000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,57000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,57000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3882000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9792000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13674000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13617000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,211000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,209000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13408000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13408000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13408000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13408000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26300000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26300000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26376456.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:08:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,34000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,34000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3184000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3184000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-3150000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3816000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10039000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13855000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17005000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,209000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-40000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,157000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16848000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16848000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16848000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16848000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26400000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.63
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26400000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.63
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26346603.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.63
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,92000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,92000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,130000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,130000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-38000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4284000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10858000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15142000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15180000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,122000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,227000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,105000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15075000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15075000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15075000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15075000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26900000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.56
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26900000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.56
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26882526.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:16:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,101000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,101000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,150000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,150000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-49000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4179000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12031000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16210000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16259000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,486000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,236000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-250000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16509000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16509000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16509000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16509000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.61
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.61
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26910284.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:12:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.61
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,114000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,114000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,114000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4252000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13290000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17542000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17428000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,515000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,224000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-291000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17719000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17719000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17719000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17719000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26800000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.66
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26800000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.66
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26966630.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:20:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.66
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,81000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,81000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,300000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,300000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-219000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4210000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15084000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19294000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19513000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,637000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,222000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-425000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19938000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19938000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19938000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19938000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26900000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.74
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26900000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.74
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26950906.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.74
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,128000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,128000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,355000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,355000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-227000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5927000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15295000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21222000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21449000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,721000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,197000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-524000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21973000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21973000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21973000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21973000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27500000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.8
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27500000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.8
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27295842.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:46:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.8
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5486000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17959000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,343000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23788000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23788000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,976000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,307000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-669000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24457000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24457000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24457000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24457000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.74
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.74
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33074463.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 16:09:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.74
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,126000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,126000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,126000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4579000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18101000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,151000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22831000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22705000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1010000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,284000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-726000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23431000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23431000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23431000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23431000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33000000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.71
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33000000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.71
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33178611.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 16:17:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.71
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-69000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-69000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,509000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,509000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-578000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5053000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14308000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-494000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18867000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19445000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2751000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,267000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2473000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21918000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21918000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21918000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21918000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31800000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.69
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31800000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.69
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31714164.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.69
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,154000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,154000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,30000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,30000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,124000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5692000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16536000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22228000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22104000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1003000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,267000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-736000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22840000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22840000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22840000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22840000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33600000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.68
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33600000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33456446.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:32:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.68
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,362000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,362000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,150000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,150000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,212000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5367000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18412000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23779000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23567000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1045000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,437000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-608000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24175000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24175000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24175000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24175000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40300000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.6
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40300000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.6
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40605953.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:13:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.6
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,292000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,292000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,139000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,139000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,153000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6968000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16413000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23381000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23228000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1065000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,492000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-573000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23801000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23801000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23801000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23801000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43300000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.55
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43300000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.55
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43334727.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q3,2018-07-01,2018-09-30,2019-11-06 17:00:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.55
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,312000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,312000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-319000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-319000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,631000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6971000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20227000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27198000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26567000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1086000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,443000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-653000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27220000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27220000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27220000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27220000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,4000000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-6.81
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,4000000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-6.81
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,4023058.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-6.81
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,516000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,516000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,516000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7536000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16848000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24384000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23868000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1070000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,410000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-660000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24528000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24528000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24528000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24528000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,4424389.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.54
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,4424389.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.54
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,4400000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:56:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.54
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1391000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1391000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,173000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,173000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1218000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7518000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19859000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27377000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26159000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1088000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,311000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-777000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26936000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26936000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26936000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26936000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46400000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.58
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46400000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.58
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46052348.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:13:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.58
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,103000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,103000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,103000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9209000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14331000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23540000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23437000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1079000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,323000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7839000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8595000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32032000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32032000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32032000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32032000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.68
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47100000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.68
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47208958.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q3,2019-07-01,2019-09-30,2019-11-06 17:00:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.68
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5133000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5133000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-173000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-173000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5306000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5709000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13497000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19206000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13900000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1043000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,307000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-14345000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15081000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28981000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28981000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28981000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28981000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,4700000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-6.17
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,4700000.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-6.17
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,4684711.0
Bellicum Pharmaceuticals Inc,BLCM,,0001358403,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-6.17
